Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacy-Based Nonprescription Viagra Sales Expand In U.K.

This article was originally published in The Tan Sheet

Executive Summary

U.K. pharmacy chain Alliance Boots expanded its program to sell Pfizer's Viagra erectile dysfunction drug without a prescription through pharmacists

You may also be interested in...



Pfizer in talks to launch consumer ED product

Undeterred by challenges to switching Viagra (sildenafil), Pfizer is reportedly developing a new Viagra-like erectile dysfunction product in the U.K. that it hopes to sell directly to consumers, according to 1Campaign, an advertising industry publication. A Pfizer spokeswoman would not confirm the potential launch, but noted in an e-mail that the firm "routinely evaluates" drug delivery and formulations. The New York-based firm withdrew its centralized switch application in the EU for Viagra November 2008 for further evaluation after regulators expressed health safety concerns (2"The Tan Sheet" Nov. 24, 2009). Health concerns include negative interactions with nitrates for blood pressure. According to Campaign, Pfizer wants to launch the product in 2011. It reports the product includes the same ingredient as Viagra, but is modified slightly. U.K. pharmacy chain Alliance Boots already sells Rx Viagra without a prescription through pharmacists at 29 stores under the country's Quality Care Commission regulations. A pilot Boots launched in 2007 showed pharmacists effectively could determine whether customers should use Viagra and that the program would prevent abuse by consumers trying to buy the drug for recreational purposes, the chain said in June 2009. Customers must register for the service with Boots and agree to have their doctors notified that they are buying Viagra (3"The Tan Sheet" June 29, 2009)

Pfizer in talks to launch consumer ED product

Undeterred by challenges to switching Viagra (sildenafil), Pfizer is reportedly developing a new Viagra-like erectile dysfunction product in the U.K. that it hopes to sell directly to consumers, according to 1Campaign, an advertising industry publication. A Pfizer spokeswoman would not confirm the potential launch, but noted in an e-mail that the firm "routinely evaluates" drug delivery and formulations. The New York-based firm withdrew its centralized switch application in the EU for Viagra November 2008 for further evaluation after regulators expressed health safety concerns (2"The Tan Sheet" Nov. 24, 2009). Health concerns include negative interactions with nitrates for blood pressure. According to Campaign, Pfizer wants to launch the product in 2011. It reports the product includes the same ingredient as Viagra, but is modified slightly. U.K. pharmacy chain Alliance Boots already sells Rx Viagra without a prescription through pharmacists at 29 stores under the country's Quality Care Commission regulations. A pilot Boots launched in 2007 showed pharmacists effectively could determine whether customers should use Viagra and that the program would prevent abuse by consumers trying to buy the drug for recreational purposes, the chain said in June 2009. Customers must register for the service with Boots and agree to have their doctors notified that they are buying Viagra (3"The Tan Sheet" June 29, 2009)

Pfizer in talks to launch consumer ED product

Undeterred by challenges to switching Viagra (sildenafil), Pfizer is reportedly developing a new Viagra-like erectile dysfunction product in the U.K. that it hopes to sell directly to consumers, according to 1Campaign, an advertising industry publication. A Pfizer spokeswoman would not confirm the potential launch, but noted in an e-mail that the firm "routinely evaluates" drug delivery and formulations. The New York-based firm withdrew its centralized switch application in the EU for Viagra November 2008 for further evaluation after regulators expressed health safety concerns (2"The Tan Sheet" Nov. 24, 2009). Health concerns include negative interactions with nitrates for blood pressure. According to Campaign, Pfizer wants to launch the product in 2011. It reports the product includes the same ingredient as Viagra, but is modified slightly. U.K. pharmacy chain Alliance Boots already sells Rx Viagra without a prescription through pharmacists at 29 stores under the country's Quality Care Commission regulations. A pilot Boots launched in 2007 showed pharmacists effectively could determine whether customers should use Viagra and that the program would prevent abuse by consumers trying to buy the drug for recreational purposes, the chain said in June 2009. Customers must register for the service with Boots and agree to have their doctors notified that they are buying Viagra (3"The Tan Sheet" June 29, 2009)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel